Cargando…

The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of adjuvant treatment and survival

AIM: We investigated whether or not postoperative complications (POCs) themselves have a negative survival impact or indirectly worsen the survival due to insufficient adjuvant chemotherapy in a pooled analysis of two large phase III studies performed in Japan PATIENTS AND METHODS: The study examine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoyama, Toru, Oba, Koji, Honda, Michitaka, Muto, Masaru, Mayanagi, Shuhei, Maeda, Hiromichi, Kanda, Mitsuro, Kashiwabara, Kosuke, Sakamoto, Junichi, Yoshikawa, Takaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232630/ https://www.ncbi.nlm.nih.gov/pubmed/37039949 http://dx.doi.org/10.1007/s10147-023-02332-y

Ejemplares similares

Clinical impact of tumor location on the colon cancer survival and recurrence: analyses of pooled data from three large phase III randomized clinical trials
por: Aoyama, Toru, et al.
Publicado: (2017)

Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials
por: Maeda, Hiromichi, et al.
Publicado: (2017)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients’ data from three large phase III randomized trials
por: Aoyama, Toru, et al.
Publicado: (2017)

Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials
por: Honda, Michitaka, et al.
Publicado: (2017)

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol
por: Namikawa, Tsutomu, et al.
Publicado: (2018)

Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer
por: Munemoto, Yoshinori, et al.
Publicado: (2015)

Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
por: Ishibashi, Keiichiro, et al.
Publicado: (2021)

Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial)
por: Okuno, Kiyotaka, et al.
Publicado: (2017)

The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2018)

Is the measurement of drain amylase content useful for predicting pancreas-related complications after gastrectomy with systematic lymphadenectomy?
por: Nakanishi, Koki, et al.
Publicado: (2020)

Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial
por: Oba, Koji, et al.
Publicado: (2006)

The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma—including the analysis of clinicopathological factors influencing relative dose intensity
por: Yabusaki, Norimitsu, et al.
Publicado: (2016)

Meta-analysis of randomized clinical trials in the era of individual patient data sharing
por: Kawahara, Takuya, et al.
Publicado: (2018)

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
por: Hattori, Norifumi, et al.
Publicado: (2019)

Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)
por: Nakamura, Masato, et al.
Publicado: (2016)

The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
por: Hayashi, Naomi, et al.
Publicado: (2020)

Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine
por: Aoyama, Toru, et al.
Publicado: (2017)

Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy
por: Murakawa, Masaaki, et al.
Publicado: (2017)

Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose–Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data
por: Furihata, Kei, et al.
Publicado: (2020)

Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 Trial
por: Ishigami, Hironori, et al.
Publicado: (2021)

Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials
por: Maeda, Hiromichi, et al.
Publicado: (2019)

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study
por: Soda, Hitoshi, et al.
Publicado: (2015)

Distinctive clinical features of human bocavirus in children younger than 2 years
por: Moriyama, Yoko, et al.
Publicado: (2010)

Surveillance of Esophageal Cancer in the Republic of Uzbekistan from 2000 to 2018
por: Yusupbekov, Abror, et al.
Publicado: (2020)

Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter
por: Yamada, Suguru, et al.
Publicado: (2016)

Increased Red Blood Cell Distribution Width in the First Year after Diagnosis Predicts Worsening of Systemic Sclerosis-Associated Interstitial Lung Disease at 5 Years: A Pilot Study
por: Ebata, Satoshi, et al.
Publicado: (2021)

Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer
por: Iwamoto, Shigeyoshi, et al.
Publicado: (2018)

The Clinical Pathway with Regional Alliance (CPRA) system for proximal femoral fractures in the southern region of Ibaraki prefecture: comparison of the proportion of patients who return to living at home from acute care and rehabilitation (kaihukuki) hospitals
por: Suzuki, Koji, et al.
Publicado: (2019)

A Methylene Blue–assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer: A Prospective, Randomized, Controlled Study
por: Aoyama, Toru, et al.
Publicado: (2015)

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
por: Aoyama, Toru, et al.
Publicado: (2014)

Rare Clinical Course of Immunoglobulin G4-Related Inflammatory Abdominal Aortic Aneurysm with Multiple Rare Complications
por: Naito, Yuji, et al.
Publicado: (2019)

Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer
por: Inaoka, Kenichi, et al.
Publicado: (2017)

Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
por: Maeda, Hiromichi, et al.
Publicado: (2014)

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy
por: Miwa, Takashi, et al.
Publicado: (2019)

Preoperative predictors of postoperative complications after gastric cancer resection
por: Kanda, Mitsuro
Publicado: (2019)

Correction to: Preoperative predictors of postoperative complications after gastric cancer resection
por: Kanda, Mitsuro
Publicado: (2020)

Unique solvability of a crack problem with Signorini-type and Tresca friction conditions in a linearized elastodynamic body
por: Kashiwabara, Takahito, et al.
Publicado: (2022)

Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial
por: Oshima, Takashi, et al.
Publicado: (2022)

Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy
por: Aoyama, Toru, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dhqf2u07a4aj2ik5v46ot3coil